Suryacipta's Tenant: PT Beta Pharmacon

History and Growth

Beta Pharmacon was established on October 28, 2011, as a subsidiary of Dexa Group, one of Indonesia’s leading pharmaceutical companies. The company was founded to contribute to the National Health Insurance (JKN) program by providing high-quality and affordable medicines. The name “Beta Pharmacon” reflects the company’s commitment to serving the nation in the pharmaceutical sector.

Vision and Mission

Beta Pharmacon aims to become a leading pharmaceutical company and a trusted partner by producing high-quality products with a focus on efficiency, optimization, and continuous improvement. The company strives to add value for customers and promote public health and welfare on a national scale.

Manufacturing Expertise and Facilities

The company’s manufacturing facilities are designed to meet Good Manufacturing Practice (GMP) standards and are continually updated. Key facilities include:

1. Quality Control Laboratory: Equipped with modern instruments for chemical-physical analysis, microbiology, stability testing, and sample retention.
2. Storage Facilities (Warehouse): Implementing a high-racking system with temperature control to store raw materials, packaging materials, and finished goods.
3. Production Facilities: Capable of producing various dosage forms, including non-betalactam tablets, coated tablets, oral liquids, and soft capsules.

The company adopts lean manufacturing concepts and modular systems to ensure efficient and high-quality production processes.

Products and Services

Beta Pharmacon produces a range of pharmaceutical products, including:

• Non-betalactam Tablets and Coated Tablets
• Non-betalactam Oral Liquids
• Non-betalactam Soft Capsules

These products are distributed to various healthcare institutions across Indonesia, supporting the nation’s healthcare needs.

Certifications

Beta Pharmacon holds various certifications that demonstrate its commitment to quality and compliance with industry standards. The certifications include:

Good Manufacturing Practice (GMP) Certification Non-Betalactam Tablets and Coated Tablets: Issued by the Indonesian Food and Drug Authority (BPOM), valid from February 2019 to February 2024.

Good Manufacturing Practice (GMP) Certification Non-Betalactam Oral Liquids: Issued by BPOM, valid from January 2018 to January 2023.

Good Manufacturing Practice (GMP) Certification Non-Betalactam Soft Capsules: Issued by BPOM, valid from August 2021 to July 2026.

Good Traditional Medicine Manufacturing Practice (CPOTB) Certification for Oral Liquid Traditional Medicines: Issued by BPOM, valid from August 2018 to August 2023.

Halal Assurance System Certification: Granted by the Assessment Institute for Foods, Drugs, and Cosmetics of The Indonesian Council of Ulama (LPPOM MUI), valid from July 2021 to July 2025.

Authorized Economic Operator (AEO) Certification: Issued by the Ministry of Finance of the Republic of Indonesia, valid from December 2021 to December 2026.

These certifications highlight PT. Beta Pharmacon’s dedication to maintaining high-quality standards, ensuring regulatory compliance, and delivering safe and effective pharmaceutical products.

Commitment to Quality

Beta Pharmacon operates under the Beta Pharmacon Quality Management System (BEST), ensuring that all manufacturing processes adhere to verified and validated standard procedures. The company emphasizes continuous improvement to meet and exceed quality standards, aligning with advancements in the pharmaceutical industry.

Headquarters

Address: Kawasan Industri Suryacipta, Jalan Surya Madya Kav.1 No.18 C, Kutanegara, Ciampel, Karawang, West Java, 41363, Indonesia.

Phone: +62 21 7454-111

Email: info@dexagroup.com

LinkedIn: Beta Pharmacon – Dexa Group

Website: Beta Pharmacon

Through its dedication to quality and innovation, PT. Beta Pharmacon continues to play a significant role in enhancing public health in Indonesia.